This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Dec 20;301(25):1382-5.

doi: 10.1056/NEJM197912203012506.

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide

R Lahita, J Kluger, D E Drayer, D Koffler, M M Reidenberg

PMID: 91972
DOI: 10.1056/NEJM197912203012506

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide

R Lahita et al. N Engl J Med. 1979.

. 1979 Dec 20;301(25):1382-5.

doi: 10.1056/NEJM197912203012506.

Authors

R Lahita, J Kluger, D E Drayer, D Koffler, M M Reidenberg

PMID: 91972
DOI: 10.1056/NEJM197912203012506

No abstract available

PubMed Disclaimer

Similar articles

Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
Reidenberg MM, Drayer DE. Reidenberg MM, et al. Angiology. 1986 Dec;37(12 Pt 2):968-71. Angiology. 1986. PMID: 2433971
Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
Dixon JA, Mulhern LM, Whiteside TL, Luksick J. Dixon JA, et al. J Rheumatol. 1980 Jul-Aug;7(4):544-6. J Rheumatol. 1980. PMID: 6999152
Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
Kluger J, Drayer DE, Reidenberg MM, Lahita R. Kluger J, et al. Ann Intern Med. 1981 Jul;95(1):18-23. doi: 10.7326/0003-4819-95-1-18. Ann Intern Med. 1981. PMID: 6166229
[Antinuclear antibodies in connective tissue diseases (author's transl)].
Homma M. Homma M. Ryumachi. 1978 May;18(3):195-203. Ryumachi. 1978. PMID: 351835 Review. Japanese. No abstract available.
DNA antibodies in systemic lupus erythematosus and pseudolupus syndrome.
Chubick A. Chubick A. Adv Intern Med. 1980;26:467-87. Adv Intern Med. 1980. PMID: 7013443 Review. No abstract available.

See all similar articles

Cited by

Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro.
Rubin RL, Curnutte JT. Rubin RL, et al. J Clin Invest. 1989 Apr;83(4):1336-43. doi: 10.1172/JCI114020. J Clin Invest. 1989. PMID: 2539397 Free PMC article.
The role of active metabolites in drug toxicity.
Pirmohamed M, Kitteringham NR, Park BK. Pirmohamed M, et al. Drug Saf. 1994 Aug;11(2):114-44. doi: 10.2165/00002018-199411020-00006. Drug Saf. 1994. PMID: 7945999 Review.
Low-dose procainamide: low risk of complications with long-term use.
van Pham C, Noguchi J, Quismorio FP Jr, Haywood LJ. van Pham C, et al. J Natl Med Assoc. 1983 Jul;75(7):705-8. J Natl Med Assoc. 1983. PMID: 6887275 Free PMC article.
Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.
Rubin RL, Bell SA, Burlingame RW. Rubin RL, et al. J Clin Invest. 1992 Jul;90(1):165-73. doi: 10.1172/JCI115832. J Clin Invest. 1992. PMID: 1378852 Free PMC article.
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.
Harron DW, Brogden RN. Harron DW, et al. Drugs. 1990 May;39(5):720-40. doi: 10.2165/00003495-199039050-00007. Drugs. 1990. PMID: 1693889 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.